ArticleMolecules (Basel, Switzerland)2022

Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia.

Valeria Ciaffaglione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.